Breaking News

National Association of Community Health Centers Calls On Congress “To Move Urgently” To Tackle 340B Contract Pharmacy Impasse “Before It’s Too Late”

After the government’s Administrative Dispute Resolution panel dismissed its complaint against drug manufacturers, NACHC is calling for Congress to take urgent action to address the contract pharmacy impasse.

Sparked by the dismissal of its complaint against Astra Zeneca and Sanofi by the government’s Administrative Dispute Resolution Panel (ADR), the National Association of Community Health Centers say “they cannot wait any longer for a solution,” to the two-year standoff

Read More »

News Alert

Feds Tell Court They Oppose Health Center’s Effort to Sink 340B Patient Definition

Genesis Health Care, FQHC
Lawyers for HHS and HRSA told a federal district court yesterday the agencies oppose a health center’s efforts to have the longstanding 340B program definition of patient declared illegal.

Lawyers for federal healthcare officials told a federal district court yesterday that the government opposes a South Carolina health center’s efforts to have the longstanding 340B program definition of patient declared illegal.

Please Login

Read More »

Court Upholds $23 Million Judgement Against CVS Caremark for Unfair Pharmacy Reimbursement

Arcade claw game
CVS Caremark must pay AIDS Healthcare Foundation $23 million for Part D drug reimbursement that the PBM clawed back from AHF unfairly, a court says.

A federal district court in Arizona has upheld a $23 million arbitration award to the AIDS Healthcare Foundation (AHF) against pharmacy benefits manager (PBM) CVS Caremark for unfair drug reimbursement.

Please Login or Become

Read More »

Feds Tell Judge They Accept that Part B Drug Payment Cuts in 2020-22 Were Unlawful

HHS
Federal lawyers told a judge that they do not oppose declaring unlawful Part B drug payments cuts for 340B hospital from 2020-2022.

Federal lawyers last week agreed with national groups that represent 340B hospitals that the U.S. Supreme Court’s June decision to declare illegal Medicare Part B payment cuts in 2018 and 2019 for hospitals’ 340B-purchased drugs “effectively resolves” the

Read More »

Arkansas’ Novel 340B Contract Pharmacy Law Doesn’t Conflict with Federal Law, State Officials Tell Court

Arkansas Insurance Department
The Arkansas insurance commissioner and 340B covered entities told a federal district judge that a state law requiring drug makers to honor 340B contract pharmacy arrangements does not conflict with federal laws.

Arkansas’s first-of-its-kind law requiring drug makers to honor 340B pricing when covered entities use contract pharmacies to dispense 340B drugs is not preempted by the federal 340B statute since the state law applies only to the acquisition and

Read More »

Judge Issues Stay in Merck’s 340B Contract Pharmacy Lawsuit

Merck
A federal district judge in Washington, D.C., put drug manufacturer Merck’s 340B contract pharmacy lawsuit against the federal government on hold pending a related federal appeals court decision.

A federal district judge in Washington, D.C., put drug manufacturer Merck’s 340B contract pharmacy lawsuit against the federal government on hold until after a federal circuit court in Washington rules in Novartis and United Therapeutics’ 340B contract pharmacy

Read More »

340B Provider Groups Decry Federal Judge’s PrEP Coverage Decision

PrEP
340B HIV provider groups have condemned a federal court decision that mandating private health insurance coverage of PrEP, a daily medication used to prevent HIV infection, is unconstitutional.

340B HIV provider groups have slammed a recent federal court decision that could have far-reaching implications on access to a host of preventive health care services.

Please Login or Become a Paid Subscriber to

Read More »

Judge Dismisses 340B Contract Pharmacy-Related Antitrust Claims Against Insulin Manufacturers

Federal District Court Rochester, N.Y.
A federal district judge in Rochester, N.Y., has dismissed two community health centers’ antitrust suit against insulin manufacturers over the companies’ 340B pricing policies.

A federal district judge has dismissed two community health centers’ federal and state antitrust claims against four insulin and diabetes drug manufacturers over the companies’ denials of 340B pricing when covered entities use contract pharmacies.

Read More »

Judge Continues Stay in 340B Dispute Resolution Lawsuit

340B, Administrative dispute resolution, HHS
A federal district judge continued the stay in community health centers’ lawsuit over the 340B administrative dispute resolution process.

A federal district judge on Wednesday continued the stay in community health centers’ lawsuit against federal health officials over the administrative dispute resolution process for the 340B program after accepting the explanation for a missed deadline to file

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report